Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Cancer treatments have come a long way — but experts say detection still lags dangerously behind. At Octane's Medical Innovation Forum 2026, oncologists argued that the real breakthrough needed now is catching cancer years, even decades, before symptoms appear. From blood tests that detect ovarian cancer before it's technically cancer, to studying the tumor microenvironment, the field is pushing for a radical rethink of early detection.
Cancer treatment has made remarkable strides — oncologists are now cautiously using the word "cure" for multiple myeloma — but leading experts say the next major leap must come in early detection. At Octane's Medical Innovation Forum 2026, a panel of oncologists made a compelling case that catching cancer earlier, sometimes decades before diagnosis, could be the most transformative shift in cancer care yet.
The science behind this push is striking. Pancreatic cancer can incubate for nearly 20 years before a patient walks into a clinic. Breast cancer cells can lie dormant in the liver for two decades before the microenvironment shifts and allows them to grow. Researchers are now studying exosomes — tiny nanovesicles cancer cells use to communicate — as more sophisticated early-detection tools, alongside a newly published blood test capable of detecting ovarian cancer up to 8–10 years before any symptoms appear.
Key Takeaways:
Why it matters: Early detection isn't just a clinical goal — it's a paradigm shift. If cancer can be intercepted before it becomes cancer, treatment could become far less aggressive and far more effective, fundamentally changing patient outcomes.